FDA Inspection 1290444 — Keystone Industries

Keystone Industries — FEI 3010002722

The FDA completed an inspection of Keystone Industries on Nov 7, 2025 in Gibbstown, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 7, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gibbstown, NJ (United States)

Citations

IDCFRDescription
184221 CFR 211.84(d)(1)Component identity verification

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.